Jump to content

3,4-Methylenedioxy-N-hydroxyamphetamine: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)
m External links: remove template per TFD; gen fixes
Line 51: Line 51:
{{Monoamine releasing agents}}
{{Monoamine releasing agents}}
{{Phenethylamines}}
{{Phenethylamines}}
{{PiHKAL}}


{{DEFAULTSORT:Methylenedioxy-N-hydroxyamphetamine, 3,4-}}
{{DEFAULTSORT:Methylenedioxy-N-hydroxyamphetamine, 3,4-}}

Revision as of 14:44, 30 July 2020

3,4-Methylenedioxy-N-hydroxyamphetamine
Clinical data
ATC code
  • none
Legal status
Legal status
Identifiers
  • 1-(1,3-Benzodioxol-5-yl)-N-hydroxypropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H13NO3
Molar mass195.218 g·mol−1
3D model (JSmol)
  • CC(CC1=CC2=C(C=C1)OCO2)NO

3,4-Methylenedioxy-N-hydroxyamphetamine (MDOH, MDH, N-hydroxytenamphetamine) is an entactogen, psychedelic, and stimulant of the phenethylamine and amphetamine chemical classes. It is the N-hydroxy homologue of MDA, and the N-desmethyl homologue of MDHMA. MDOH was first synthesized and assayed by Alexander Shulgin.[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), Shulgin listed the dosage range as 100–160 mg, and the duration as approximately 3–6 hours.[1] He describes MDOH as being very psychedelic and producing increased pleasure in beauty and nature.[1] He also mentioned several negative side effects also seen with MDMA ("Ecstasy") such as difficulty urinating and internal dryness.[1]

References

  1. ^ a b c d Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.